Results 101 to 110 of about 1,418,988 (256)
Proton pump inhibitor use and hospitalization with hypomagnesemia stratified by diuretic use.
aAdjusted for diabetes, congestive heart failure, malignancy, steroid use, and number of distinct drugs used in the past year (excluding PPI).Proton pump inhibitor use and hospitalization with hypomagnesemia stratified by diuretic use.
Nina Lathia (636440) +7 more
core +1 more source
Heteroatom precursor engineering serves as a molecular‐level strategy to tailor hydrazide monomer reactivity and diffusion kinetics, enabling controlled assembly of highly crystalline COF membranes with ultramicroporous channels. The nitrogen‐enriched nanochannels deliver high water/ion selectivity via simultaneous water transport acceleration and ion ...
Guishan Hu +8 more
wiley +1 more source
IL‐1β upregulates the protein level of WTAP, which promotes the m6A modification of ACSL4 mRNA in an IGF2BP2‐dependent manner, thereby enhancing its stability. The increased ACSL4 drives lipid peroxidation, leading to lysosomal membrane permeabilization (LMP) and impaired mitophagy, which collectively accelerate intervertebral disc degeneration (IVDD).
Shu Jia +8 more
wiley +1 more source
Proton-pump inhibitors used in the out-patient clinic.
Proton-pump inhibitors used in the out-patient clinic.
Joonbyung Park (5746610) +8 more
core +1 more source
The injectable CeTA@GPP hydrogel is administered via intrauterine injection, forming a protective barrier. In the high ROS inflammatory microenvironment of injured endometrium, boronate ester cleavage triggers responsive CeTA release and local enrichment.
Peixian Cheng +8 more
wiley +1 more source
[A&T]MLN is a triple‐modal nanoplatform with siRNA‐loaded LN coated with hybrid ACE2/macrophage membrane. It blocks viral entry, neutralizes IL‐6/IL‐1β/TNF‐α, and delivers siRNA to suppress viral replication. In a murine lung injury model, it attenuates inflammation, offering a multi‐pronged strategy against SARS‐CoV‐2 variants and hyperinflammation ...
Hui Li +19 more
wiley +1 more source
A bioactive poly(citrate‐polyglycol‐procyanidin) (PCGP) nanoshield is developed for cardiovascular implants to restore endothelial mitochondrial homeostasis following vascular injury. By preserving mitochondrial integrity, re‐establishing metabolic balance, and activating PI3K/Akt/eNOS‐NO signaling, the PCGP interface promotes functional endothelial ...
Xiyu Liu +14 more
wiley +1 more source
Improving Proton-Pump Inhibitor Adherence Intervention Between Primary Care and Community Pharmacies: A Pre-Post Intervention Study [PDF]
María Puig-Moltó,1 Blanca Lumbreras,1,2 Elsa López-Pintor2,3 1Department of Public Health, History of Science and Gynecology, Miguel Hernandez University, San Juan de Alicante, Spain; 2CIBER of Epidemiology and Public Health, CIBERESP, Madrid, Spain ...
Lumbreras B +2 more
core
A carrier‐free zinc‐coordinated polyphenol nanoplatform (ZnCA NPs) is designed as an “all‐in‐one” therapeutic strategy for intestinal inflammation. The ZnCA NPs exhibit enhanced colonic accumulation and broad‐spectrum reactive oxygen and nitrogen species scavenging.
Qiwen Xie +7 more
wiley +1 more source
Determinants of proton pump inhibitor prescription behavior: a systematic scoping review protocol
A systematic scoping literature review to identify determinants of proton pump inhibitor prescription ...
Laurens van Gestel +4 more
core +1 more source

